A Rare Lymphoproliferative Disease: Castleman Disease
Open Access
- 1 January 2021
- journal article
- research article
- Published by Galenos Yayinevi in Turkish Journal of Hematology
- Vol. 38 (4) , 314-320
Abstract
Castleman disease is a rare lymphoproliferative disease also known as angiofollicular lymph node hyperplasia. It is classified as hyaline vascular and plasmacytic variants histologically but characteristics of both types can coexist. Most unicentric cases of the disease are hyaline vascular while most multicentric cases are of the plasmacytic type. Although the pathogenesis is not completely understood, the role of interleukin (IL)-6 in unicentric disease and the roles of IL-6 and human herpes virus-8 in multicentric disease are well defined. Unicentric disease is typically localized and symptoms are minimal and treated locally. Multicentric disease is systemic and clinically characterized by generalized lymphadenopathy, splenomegaly, anemia, and systemic inflammatory symptoms. Systemic therapies are primarily given. Several malignant diseases including lymphomas, POEMS syndrome, follicular dendritic cell sarcomas, paraneoplastic pemphigus, Kaposi sarcoma, and amyloidosis can be associated with Castleman disease. In this paper, recent information about Castleman disease, which is a rare disease, is summarized.Keywords
This publication has 34 references indexed in Scilit:
- Efficacy of lenalidomide in POEMS syndrome: A retrospective study of 20 patientsAmerican Journal of Hematology, 2012
- Human Herpesvirus 8–Related Castleman Disease in the Absence of HIV InfectionClinical Infectious Diseases, 2012
- The spectrum of Castleman's disease: Mimics, radiologic pathologic correlation and role of imaging in patient managementEuropean Journal of Radiology, 2012
- Castleman diseaseThe Korean Journal of Hematology, 2012
- Clinical Features and Outcome in HIV-Associated Multicentric Castleman's DiseaseJournal of Clinical Oncology, 2011
- A retrospective study of unicentric and multicentric Castleman’s disease: a report of 52 patientsMedical Oncology, 2009
- Castleman DiseaseAdvances in Anatomic Pathology, 2009
- The successful treatment of haemophagocytic syndrome in patients with human immunodeficiency virus-associated multi-centric Castleman's diseaseClinical and Experimental Immunology, 2008
- Life-threatening interaction between antiretroviral therapy and vinblastine in HIV-associated multicentric Castleman's diseaseEuropean Journal of Haematology, 2006
- Treatment of castleman’s diseaseCurrent Treatment Options in Oncology, 2005